The Lancet Haematology has published an editorial praising the work the World Federation of Hemophilia (WFH) is doing for the global bleeding disorders community. The editorial specifically mentions the successful WFH Virtual Summit, and the 2019 WFH Annual Global Survey (AGS). Also covered is the impact made by the WFH Humanitarian Aid Program and the WFH Guidelines for the Management of Hemophilia (of which the third edition will be released soon). A strong theme in the editorial is the effort the WFH has put into raising awareness for bleeding disorders worldwide, and the importance of the data-rich resources the WFH has developed. The Lancet Haematology indicates that thanks to the data the WFH collects, researchers, health care professionals, patients and advocates have the information they need to effectively do their part to push the WFH vision of Treatment for All.
To read Bleeding disorders: making strides towards treatment for all in The Lancet Haematology, please click here.
About the WFH Humanitarian Aid Program
The WFH Humanitarian Aid Program improves the lack of access to care and treatment by providing much-needed support for people with inherited bleeding disorders in developing countries. By providing patients with a more predictable and sustainable flow of humanitarian aid donations, the WFH Humanitarian Aid Program makes it possible for patients to receive consistent and reliable access to treatment and care. None of this would be possible without the generous support of Sanofi Genzyme and Sobi, our Founding Visionary Contributors; Bayer, our Visionary Contributor; Grifols and Roche, our Leadership Contributors; and our Contributor, CSL Behring. To learn more about the WFH Humanitarian Aid Program, visit www.treatmentforall.org.